STRATA Skin Sciences, Inc. (SSKN)
STRATA Skin Sciences, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Horsham, PA, US. The stock last traded at $0.00, down 98.18% on the session, giving a market capitalisation of $465. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -21.1%. Its beta of -0.05 implies it has historically moved less than the broad market.
STRATA Skin Sciences, Inc. is an innovative medical technology enterprise dedicated to the development, commercialization, and marketing of advanced products specifically designed for treating a range of dermatologic conditions. The company operates through two main divisions: Dermatology Recurring Procedures and Dermatology Procedures Equipment. With a substantial global footprint, STRATA Skin Sciences distributes its solutions across the United States, Europe, the Middle East, Asia, Australia, South Africa, and both Central and South America. Its notable product portfolio includes the XTRAC and Pharos excimer laser systems, VTRAC lamp systems, and TheraClear treatment solutions. These technologies are instrumental in addressing common skin ailments such as psoriasis, vitiligo, and acne, among others. Domestically, the company engages directly with physicians for product distribution, while leveraging a network of international distributors to reach markets beyond the U.S. Established in 1989 and headquartered in Horsham, Pennsylvania, the company adopted its current name, STRATA Skin Sciences, Inc., in January 2016, having previously operated as MELA Sciences, Inc.
STRATA Skin Sciences, Inc. is most often compared with the following Healthcare names: